A copy of this work was available on the public web and has been preserved in the Wayback Machine. The capture dates from 2022; you can also visit the original URL.
The file type is application/pdf
.
The changing therapeutic landscape of spinal muscular atrophy
2022
The clinical approach to spinal muscular atrophy (SMA) has changed, and the condition is now a treatable neurodegenerative disease, with treated infants and children experiencing gains in motor function and significant increases in survival. Consequently, it is important for primary care physicians to be aware of their role in both detection and community support of people with SMA and their families. The aim of this article is to discuss the pertinent features of SMA relevant to the primary
doi:10.31128/ajgp-03-21-5924
pmid:35098272
fatcat:slzevcqsvjelnitvyksjhkoc5y